United States of America et al v. Organon USA Inc et al

  1. May 01, 2018

    PharMerica Beats Final Claims In 2007 Kickback Lawsuit

    Nursing home pharmacy chain PharMerica Corp. escaped a False Claims Act case unblemished on Tuesday, joining two other companies that settled without admitting culpability in the 11-year-old whistleblower suit that once sought $421 million in Massachusetts federal court.

  2. October 16, 2017

    PharMerica Says FCA Whistleblowers Got Info Secondhand

    PharMerica Inc. and two whistleblowers accusing the company of accepting kickbacks from drugmaker Organon USA Inc. on Friday sparred in Massachusetts federal court over whether the relators are eligible to bring a False Claims Act lawsuit, as the company claims they didn't get their information firsthand.

  3. October 05, 2017

    PharMerica Must Face State FCA Claims, Whistleblowers Say

    Two whistleblowers accusing PharMerica Inc. of accepting kickbacks from drugmaker Organon USA Inc. have asked a Massachusetts federal court to revive claims dismissed in 2012, arguing claims under various state False Claims Acts aren't blocked by the first-to-file bar, according to a motion filed Wednesday.

  4. October 02, 2017

    PharMerica Looks To Duck Last Claims In Kickback Suit

    PharMerica Corp. urged a Massachusetts federal court on Friday to nix the three remaining claims asserted against it by whistleblowers who have alleged the pharmacy company took kickbacks from drugmaker Organon for prescribing an antidepressant drug.

  5. May 26, 2017

    Omnicare Pays $23M To End Kickback, Medicaid Fraud Suit

    Omnicare Inc. on Thursday asked a Massachusetts federal judge to approve a $23 million settlement to end a False Claims Act case brought by whistleblowers alleging fraudulent Medicaid claims and kickbacks to pharmacies that prescribed an antidepressant drug.

  6. September 26, 2016

    PhRMA Rips Feds For 'Regulation By Litigation' On Kickbacks

    Trade group Pharmaceutical Research and Manufacturers of America has jumped into a closely watched False Claims Act case in Massachusetts federal court by accusing the U.S. Department of Justice of unconstitutionally using "regulation by litigation" to shape anti-kickback policies.

  7. September 01, 2016

    Omnicare Asks To Appeal $421M FCA Suit To 1st Circ.

    Omnicare urged a Massachusetts federal judge Wednesday to certify for appeal her decision to greenlight a $421 million False Claims Act suit alleging the pharmacy company took kickbacks from drugmaker Organon. 

  8. August 24, 2016

    Omnicare Can't Kick Whistleblower's $421M FCA Suit

    A Massachusetts federal judge on Tuesday refused to let Omnicare Inc. escape from two whistleblowers' False Claims Act suit accusing the health care company of entering into a six-year kickback agreement with drug manufacturer Organon, concluding that too many questions remain about its conduct.

  9. June 29, 2016

    'Kickbacks' In FCA Suit Were Just Discounts, Omnicare Says

    Omnicare Inc. engaged in a perfectly legal drug discount program that was studiously noted in written agreements, the company told a Massachusetts federal judge Wednesday as it pressed for summary judgment in a qui tam case alleging false Medicaid claims and kickbacks.

  10. November 27, 2012

    Texas AG Blasts Subpoena In $421M FCA Suit

    Texas' attorney general on Monday asked a Massachusetts federal judge to block a subpoena from whistleblowers in a $421 million False Claims Act lawsuit against Omnicare Inc., Organon USA Inc. and other companies, saying state Medicaid law bars release of the requested documents.